OBJECTIVES: Upon completion of this activity, the participant should be able to:
1.  Describe current progress in allogenic and autologous islet cell transplantation
2.  Discuss latest strategies for islet cell delivery and stem-cell derived islet replacement therapies

FACULTY DISCLOSURE:  Michael Lawrence, PhD has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER DISCLOSURE:  Michael Mack, MD; Jennifer Thomas, BS, MS;  Alaina Tellson PhD, RN, NPD-BC, NE-BC, have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES: Baylor Scott & White Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.